Haemonetics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
Haemonetics Corporation (NYSE: HAE) announced that CEO Chris Simon will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 8:45 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics Corporation (NYSE: HAE) announced that CEO Chris Simon will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 8:45 a.m. ET. Investors can access the live presentation via a webcast, with a replay available for 180 days post-event, starting at 12:00 p.m. ET. Haemonetics focuses on innovative medical products to enhance patient care and improve healthcare costs.
Details
News Market Reaction – HAE
The recorded move for HAE in the trading session of this news was +1.75%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Aug. 23, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 8:45 a.m. ET.
The public may access Mr. Simon's presentation live via webcast and subsequent replay at: https://event.webcasts.com/starthere.jsp?ei=1566655&tp_key=6a9e8b9f64&tp_special=8
A replay of the webcast will be available for 180 days beginning on September 12, 2022 at 12:00 pm ET using the webcast link provided in this press release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Sr. Director, Investor Relations & Treasury | David Trenk, Manager, Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Director, Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference-301611157.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.